Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Aceso Life Science Group Limited ( (HK:0474) ) has issued an announcement.
Aceso Life Science Group Limited and Hao Tian International Construction Investment Group Limited announced a delay in the dispatch of their joint circulars, which will include key information such as details of a Possible Deemed Disposal and a Placing Agreement. The dispatch date has been postponed to on or before February 17, 2025, due to additional time needed to finalize certain information. This delay may have implications for the stakeholders as it affects the timely dissemination of crucial information required under the Listing Rules.
More about Aceso Life Science Group Limited
Aceso Life Science Group Limited operates in the life sciences industry, focusing on products and services that pertain to biotechnology and possibly pharmaceutical advancements. The company engages in ventures that impact the healthcare and life sciences sectors.
YTD Price Performance: -2.00%
Average Trading Volume: 1,017,754
Technical Sentiment Consensus Rating: Buy
Current Market Cap: HK$361.7M
For a thorough assessment of 0474 stock, go to TipRanks’ Stock Analysis page.
